Renaissance Technologies’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-295,542
| Closed | -$6.41M | – | 3524 |
|
|
2017
Q2 | $6.41M | Buy |
295,542
+147,200
| +99% | +$2.67M | 0.01% | 1544 |
|
|
2017
Q1 | $2.08M | Sell |
148,342
-209,558
| -59% | -$3.43M | ﹤0.01% | 2216 |
|
|
2016
Q4 | $6.71M | Buy |
357,900
+10,658
| +3% | +$181K | 0.01% | 1482 |
|
|
2016
Q3 | $5.73M | Buy |
347,242
+229,300
| +194% | +$3.4M | 0.01% | 1515 |
|
|
2016
Q2 | $1.58M | Sell |
117,942
-205,300
| -64% | -$2.99M | ﹤0.01% | 2331 |
|
|
2016
Q1 | $4.94M | Buy |
323,242
+96,950
| +43% | +$1.52M | 0.01% | 1638 |
|
|
2015
Q4 | $4.49M | Buy |
226,292
+115,411
| +104% | +$2.19M | 0.01% | 1564 |
|
|
2015
Q3 | $1.93M | Buy |
110,881
+83,557
| +306% | +$1.7M | ﹤0.01% | 2015 |
|
|
2015
Q2 | $552K | Sell |
27,324
-34,918
| -56% | -$674K | ﹤0.01% | 2690 |
|
|
2015
Q1 | $1.09M | Sell |
62,242
-63,900
| -51% | -$1.09M | ﹤0.01% | 2263 |
|
|
2014
Q4 | $2.05M | Sell |
126,142
-83,100
| -40% | -$1.53M | 0.01% | 1778 |
|
|
2014
Q3 | $4.62M | Sell |
209,242
-370,600
| -64% | -$7.59M | 0.01% | 1211 |
|
|
2014
Q2 | $11.7M | Sell |
579,842
-116,848
| -17% | -$1.98M | 0.03% | 761 |
|
|
2014
Q1 | $13M | Buy |
696,690
+184,090
| +36% | +$2.53M | 0.03% | 719 |
|
|
2013
Q4 | $5.17M | Sell |
512,600
-84,342
| -14% | -$1.02M | 0.01% | 1179 |
|
|
2013
Q3 | $7.7M | Buy |
596,942
+3,300
| +0.6% | +$40.6K | 0.02% | 932 |
|
|
2013
Q2 | $7.05M | Buy |
+593,642
| New | +$6.43M | 0.02% | 910 |
|
Other funds holding AMRI
Renaissance Technologies's AMRI Position: Q3 2017 in Review
Renaissance Technologies sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 295,542 shares — an estimated $6.41M sold.
Renaissance Technologies first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $13M in Q1 2014. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.
- Renaissance Technologies reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
- Renaissance Technologies sold 295,542 Albany Molecular Research Inc shares in Q3 2017, an estimated $6.41M.
- Renaissance Technologies first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
- Renaissance Technologies's Albany Molecular Research Inc position peaked at $13M in Q1 2014.
- 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.